vs

Side-by-side financial comparison of HORIZON BANCORP INC (HBNC) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.

HORIZON BANCORP INC is the larger business by last-quarter revenue ($63.5M vs $57.3M, roughly 1.1× RHYTHM PHARMACEUTICALS, INC.). HORIZON BANCORP INC runs the higher net margin — 42.4% vs -83.0%, a 125.4% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 19.5%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 9.2%).

First Horizon Corporation, formerly First Tennessee Bank, is a financial services company, founded in 1864, and based in Memphis, Tennessee. Through its banking subsidiary First Horizon Bank, it provides financial services through locations in 12 states across the Southeast, a region in which it is the fourth largest regional bank.

Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.

HBNC vs RYTM — Head-to-Head

Bigger by revenue
HBNC
HBNC
1.1× larger
HBNC
$63.5M
$57.3M
RYTM
Growing faster (revenue YoY)
RYTM
RYTM
+17.4% gap
RYTM
36.9%
19.5%
HBNC
Higher net margin
HBNC
HBNC
125.4% more per $
HBNC
42.4%
-83.0%
RYTM
Faster 2-yr revenue CAGR
RYTM
RYTM
Annualised
RYTM
48.5%
9.2%
HBNC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HBNC
HBNC
RYTM
RYTM
Revenue
$63.5M
$57.3M
Net Profit
$26.9M
$-47.5M
Gross Margin
91.6%
Operating Margin
51.5%
-82.2%
Net Margin
42.4%
-83.0%
Revenue YoY
19.5%
36.9%
Net Profit YoY
347.4%
-9.6%
EPS (diluted)
$0.44
$-0.73

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HBNC
HBNC
RYTM
RYTM
Q4 25
$63.5M
$57.3M
Q3 25
$58.4M
$51.3M
Q2 25
$66.3M
$48.5M
Q1 25
$68.8M
$32.7M
Q4 24
$53.1M
$41.8M
Q3 24
$58.4M
$33.3M
Q2 24
$55.8M
$29.1M
Q1 24
$53.2M
$26.0M
Net Profit
HBNC
HBNC
RYTM
RYTM
Q4 25
$26.9M
$-47.5M
Q3 25
$-222.0M
$-52.9M
Q2 25
$20.6M
$-46.6M
Q1 25
$23.9M
$-49.5M
Q4 24
$-10.9M
$-43.3M
Q3 24
$18.2M
$-43.6M
Q2 24
$14.1M
$-32.3M
Q1 24
$14.0M
$-141.4M
Gross Margin
HBNC
HBNC
RYTM
RYTM
Q4 25
91.6%
Q3 25
89.3%
Q2 25
88.6%
Q1 25
88.8%
Q4 24
90.9%
Q3 24
88.5%
Q2 24
89.9%
Q1 24
89.2%
Operating Margin
HBNC
HBNC
RYTM
RYTM
Q4 25
51.5%
-82.2%
Q3 25
-490.4%
-102.6%
Q2 25
36.8%
-93.4%
Q1 25
40.8%
-143.7%
Q4 24
-41.3%
-98.6%
Q3 24
31.0%
-132.0%
Q2 24
28.5%
-139.2%
Q1 24
28.8%
-538.7%
Net Margin
HBNC
HBNC
RYTM
RYTM
Q4 25
42.4%
-83.0%
Q3 25
-380.2%
-103.1%
Q2 25
31.1%
-96.1%
Q1 25
34.8%
-151.4%
Q4 24
-20.5%
-103.6%
Q3 24
31.1%
-131.2%
Q2 24
25.4%
-110.9%
Q1 24
26.3%
-544.4%
EPS (diluted)
HBNC
HBNC
RYTM
RYTM
Q4 25
$0.44
$-0.73
Q3 25
$-4.69
$-0.82
Q2 25
$0.47
$-0.75
Q1 25
$0.54
$-0.81
Q4 24
$-0.25
$-0.71
Q3 24
$0.41
$-0.73
Q2 24
$0.32
$-0.55
Q1 24
$0.32
$-2.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HBNC
HBNC
RYTM
RYTM
Cash + ST InvestmentsLiquidity on hand
$139.5M
$388.9M
Total DebtLower is stronger
$248.6M
Stockholders' EquityBook value
$688.3M
$139.1M
Total Assets
$6.4B
$480.2M
Debt / EquityLower = less leverage
0.36×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HBNC
HBNC
RYTM
RYTM
Q4 25
$139.5M
$388.9M
Q3 25
$458.3M
$416.1M
Q2 25
$137.9M
$291.0M
Q1 25
$169.7M
$314.5M
Q4 24
$293.4M
$320.6M
Q3 24
$234.8M
$298.4M
Q2 24
$146.1M
$319.1M
Q1 24
$201.2M
Total Debt
HBNC
HBNC
RYTM
RYTM
Q4 25
$248.6M
Q3 25
Q2 25
Q1 25
Q4 24
$1.2B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
HBNC
HBNC
RYTM
RYTM
Q4 25
$688.3M
$139.1M
Q3 25
$660.8M
$148.8M
Q2 25
$790.9M
$-11.9M
Q1 25
$776.1M
$18.9M
Q4 24
$763.6M
$21.7M
Q3 24
$754.8M
$11.2M
Q2 24
$726.7M
$39.3M
Q1 24
$721.3M
$61.6M
Total Assets
HBNC
HBNC
RYTM
RYTM
Q4 25
$6.4B
$480.2M
Q3 25
$6.7B
$506.9M
Q2 25
$7.7B
$372.7M
Q1 25
$7.6B
$386.7M
Q4 24
$7.8B
$392.3M
Q3 24
$7.9B
$363.6M
Q2 24
$7.9B
$381.8M
Q1 24
$7.9B
$258.7M
Debt / Equity
HBNC
HBNC
RYTM
RYTM
Q4 25
0.36×
Q3 25
Q2 25
Q1 25
Q4 24
1.61×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HBNC
HBNC
RYTM
RYTM
Operating Cash FlowLast quarter
$79.2M
$-25.4M
Free Cash FlowOCF − Capex
$74.3M
FCF MarginFCF / Revenue
117.0%
Capex IntensityCapex / Revenue
7.8%
Cash ConversionOCF / Net Profit
2.94×
TTM Free Cash FlowTrailing 4 quarters
$115.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HBNC
HBNC
RYTM
RYTM
Q4 25
$79.2M
$-25.4M
Q3 25
$10.9M
$-26.6M
Q2 25
$19.5M
$-23.3M
Q1 25
$15.2M
$-40.4M
Q4 24
$6.4M
$-18.8M
Q3 24
$32.3M
$-25.2M
Q2 24
$15.9M
$-29.1M
Q1 24
$6.5M
$-40.7M
Free Cash Flow
HBNC
HBNC
RYTM
RYTM
Q4 25
$74.3M
Q3 25
$9.4M
Q2 25
$18.1M
Q1 25
$14.1M
Q4 24
$1.3M
Q3 24
$31.0M
Q2 24
$15.1M
Q1 24
$5.4M
FCF Margin
HBNC
HBNC
RYTM
RYTM
Q4 25
117.0%
Q3 25
16.1%
Q2 25
27.3%
Q1 25
20.5%
Q4 24
2.4%
Q3 24
53.1%
Q2 24
27.1%
Q1 24
10.1%
Capex Intensity
HBNC
HBNC
RYTM
RYTM
Q4 25
7.8%
Q3 25
2.6%
Q2 25
2.1%
Q1 25
1.6%
Q4 24
9.6%
Q3 24
2.2%
Q2 24
1.5%
Q1 24
2.2%
Cash Conversion
HBNC
HBNC
RYTM
RYTM
Q4 25
2.94×
Q3 25
Q2 25
0.94×
Q1 25
0.64×
Q4 24
Q3 24
1.78×
Q2 24
1.13×
Q1 24
0.47×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons